Evidence map›Paper›PMID 41794027›Full record

ArticleCell2026

Dynamics of natural selection preceding human viral epidemics and pandemics.

Jennifer L Havens, Sergei L Kosakovsky Pond, Jordan D Zehr, Jonathan E Pekar, Edyth Parker, Michael Worobey, Kristian G Andersen, Joel O Wertheim

Abstract read
In one paragraph

Article in Cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jennifer L HavensBioinformatics and Systems Biology Graduate Program, University of California - San Diego, La Jolla, CA 92093, USA; Department of Biostatistics, Fielding School of Public Health, University of California - Los Angeles, Los Angeles, CA 90095, USA. Electronic address: j.lee.havens@gmail.com.
Sergei L Kosakovsky PondInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA 19122, USA. Electronic address: spond@temple.edu.
Jordan D ZehrInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA 19122, USA; Department of Public and Ecosystem Health, Cornell University, Ithaca, NY 14850, USA.
Jonathan E PekarBioinformatics and Systems Biology Graduate Program, University of California - San Diego, La Jolla, CA 92093, USA; Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK; Department of Medicine, University of California - San Diego, La Jolla, CA 92093, USA.
Edyth ParkerDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Michael WorobeyDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, USA.
Kristian G AndersenDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Joel O WertheimDepartment of Medicine, University of California - San Diego, La Jolla, CA 92093, USA. Electronic address: jwertheim@health.ucsd.edu.

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Robert F Garry · 2018 to 2026
$32.0M
West African Emerging Infectious Disease Research Center (WA-EIDRC)U01AI151812 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ANDERSEN, KRISTIAN GRAUGAARD, GARRY, ROBERT F · 2020 to 2024
$13.2M
An in integrated platform for multiomic analyses of pathogen and host data using scalable public infrastructureU24AI183870 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI Kelsey M Beavers, Maximilian Haeussler · 2024 to 2026
$10.2M
San Diego Biomedical Informatics Education & Research (SABER)T15LM011271 · NLM · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHAMIM NEMATI · 2012 to 2026
$9.7M
Automation and Evaluation of Real-Time Transmission Network-Based HIV Prevention Services in New York CityR01AI135992 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WERTHEIM, JOEL OKRENT · 2018 to 2022
$3.6M
Statistical Innovation to Integrate Sequences and Phenotypes for Scalable Phylodynamic InferenceR01AI153044 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Marc A. Suchard · 2021 to 2026
$2.4M
Reinventing dN/dS and the study of natural selectionR01GM144468 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI HEY, EMANUEL, POND, SERGEI L KOSAKOVSKY · 2022 to 2025
$1.3M
Hypothesis Testing using Phylogenies for the 21st century (equipment supplement)R01GM151683 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Spencer V. Muse, ANTON NEKRUTENKO · 2024 to 2026
$1.2M
NIAID NIH HHS R01 AI135992NIAID NIH HHS R01 AI153044NIAID NIH HHS U01 AI151812NIAID NIH HHS U19 AI135995NIAID NIH HHS U24 AI183870NIGMS NIH HHS R01 GM144468NIGMS NIH HHS R01 GM151683NIH HHS 75N93021C00015NLM NIH HHS T15 LM011271
6 · The paper itself

Abstract

Using a phylogenetic framework to characterize natural selection, we investigate the hypothesis that zoonotic viruses require adaptation prior to zoonosis to sustain human-to-human transmission. Examining the zoonotic emergence of Ebola virus, Marburg virus, mpox virus, influenza A virus, and SARS-CoV-2, we find no evidence of a change in selection intensity immediately prior to outbreaks in humans compared with typical selection within reservoir hosts. We found a change in selection on SARS-CoV in an intermediate host. We conclude that extensive pre-zoonotic adaptation is not necessary for human-to-human transmission of zoonotic viruses. In contrast, the reemergence of H1N1 influenza A virus in 1977 was preceded by a shift in selection intensity, consistent with the hypothesis of passage in a laboratory setting. Holistic phylogenetic analysis of selection regimes can be used to detect evolutionary signals of host switching or laboratory passage, providing insight into the circumstances of past and future viral emergence.

Indexed as

Selection, GeneticAnimalsCOVID-19EbolavirusHemorrhagic Fever, EbolaHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMarburgvirusPandemicsPhylogenySARS-CoV-2Viral ZoonosesZoonoses1977 H1N1 reemergenceEbola virushost reservoirinfluenza A virusMarburg virusmpox virusSARS-CoVSARS-CoV-2selectionzoonosis

Identifiers

PMID41794027
PMCPMC13092335

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.